Research/art/teacher profile of a person
Name and surname:
RNDr. Maroš Kolomazník, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Kolomazník
I.2 - Name
Maroš
I.3 - Degrees
RNDr., PhD.
I.4 - Year of birth
1988
I.5 - Name of the workplace
Comenius University Bratislava, Jessenius faculty of medicine in Martin, Slovak Republic
I.6 - Address of the workplace
Mala hora 4A, 036 01 Martin
I.7 - Position
researcher
I.8 - E-mail address
maros.kolomaznik@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/26344
I.10 - Name of the study field in which a person works at the university
7.1.3 Normal and pathological physiology
I.11 - ORCID iD
0000-0003-0992-3058

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Constantine the Philosopher University in Nitra, Slovak Republic
II.b - Year
2010
II.c - Study field and programme
Biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Constantine the Philosopher University in Nitra, Slovak Republic
II.b - Year
2012
II.c - Study field and programme
Biology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Comenius University Bratislava, Jessenius faculty of medicine in Martin, Slovak Republic
II.b - Year
2016
II.c - Study field and programme
Normal and pathological physiology
II.4 - Associate professor
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Researcher Comenius University Bratislava, Jessenius faculty of medicine in Martin, Slovak Republic 26.08.2016 - until

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Scientific internship Experimental laboratory for surfactant research, Department of children and adolescents, Lübeck University Hospital, Germany 2013

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Physiology 1,2 General Medicine I.+II. General Medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.2 - Number of defended theses
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
131
VI.1.b - Over the last six years
65
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
44
VI.1.b - Over the last six years
18
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
356
VI.1.b - Over the last six years
74
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
327
VI.1.b - Over the last six years
68
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Kolomaznik M, Hanusrichterova J, Mikolka P, Kosutova P, Vatecha M, Zila I, Mokra D, Calkovska A. Efficiency of exogenous surfactant combined with intravenous N-acetylcysteine in two-hit rodent model of ARDS. Respir Physiol Neurobiol. 2023 Oct;316:104138. / IF=1,9; Q2

2

Kolomaznik M, Mikolka P, Hanusrichterova J, Kosutova P, Matasova K Jr, Mokra D, Calkovska A. N-acetylcysteine in mechanically ventilated rats with lipopolysaccharide-induced acute respiratory distress syndrome: The effect of intravenous dose on oxidative damage and inflammation. Biomedicines. 2021 Dec 12;9(12):1885 / IF=4,757; Q1

3

Kolomaznik M, Nova Z, Calkovska A. Pulmonary surfactant and bacterial lipopolysaccharide: the interaction and its functional consequences. Physiol Res. 2017 Sep 22;66(Suppl 2):S147-S157 / IF=1,324; Q4

4

Mikolka P, Kosutova P, Kolomaznik M, Nemcova N, Hanusrichterova J, Curstedt T, Johansson J, Calkovska A. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits. Lung. 2024 Jun;202(3):299-315. / IF=4,6; Q1

5

Zila I, Kolomaznik M, Mikolka P, Kosutova P, Czippelova B, Javorka M, Calkovska A. Vagal cardiac control in rats with LPS-induced lung injury. Respir Physiol Neurobiol. 2023 Oct;316:104120. / IF=1,9; Q2

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Kolomaznik M, Mikolka P, Hanusrichterova J, Kosutova P, Matasova K Jr, Mokra D, Calkovska A. N-acetylcysteine in mechanically ventilated rats with lipopolysaccharide-induced acute respiratory distress syndrome: The effect of intravenous dose on oxidative damage and inflammation. Biomedicines. 2021 Dec 12;9(12):1885 / IF=4,757; Q1

2

Hanusrichterova J, Kolomaznik M, Barosova R, Adamcakova J, Mokra D, Mokry J, Skovierova H, Kelly MM, de Heuvel E, Wiehler S, Proud D, Shen H, Mukherjee PG, Amrein MW, Calkovska A. Pulmonary surfactant and prostaglandin E2 in airway smooth muscle relaxation of human and male guinea pigs. Physiol Rep. 2024 Sep;12(17):e70026. / IF=2,2; Q2

3

Kolomaznik M, Hanusrichterova J, Mikolka P, Kosutova P, Vatecha M, Zila I, Mokra D, Calkovska A. Efficiency of exogenous surfactant combined with intravenous N-acetylcysteine in two-hit rodent model of ARDS. Respir Physiol Neurobiol. 2023 Oct;316:104138. / IF=1,9;Q2

4

Mikolka P, Kosutova P, Kolomaznik M, Nemcova N, Hanusrichterova J, Curstedt T, Johansson J, Calkovska A. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits. Lung. 2024 Jun;202(3):299-315. / IF=4,6; Q1

5

Zila I, Kolomaznik M, Mikolka P, Kosutova P, Czippelova B, Javorka M, Calkovska A. Vagal cardiac control in rats with LPS-induced lung injury. Respir Physiol Neurobiol. 2023 Oct;316:104120. / IF=1,9; Q2

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Ad.1 VI.2: Nájera-Martínez, Minerva - Lara-Vega, Israel - Avilez-Alvarado, Jhonatan - Pagadala, Nataraj S. - Dzul-Caamal, Ricardo - Domínguez-López, María Lilia - Tuszynski, Jack - Vega-López, Armando. 2024 "The Generation of ROS by Exposure to Trihalomethanes Promotes the IκBα/NF-κB/p65 Complex Dissociation in Human Lung Fibroblast", Biomedicines. 12, 10, 2399

2

Ad.2 VI.2: Cadegiani, F.A. 2020, "Repurposing existing drugs for COVID-19: An endocrinology perspective", BMC Endocrine Disorders, 20(1), 149

3

Ad.3 VI.2: Aboudounya, M.M., Heads, R.J. 2021, " COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation", Mediators of Inflammation 2021, 8874339

4

Ad.4 VI.2: Loftus, C.A., Soler, Z.M., Koochakzadeh, S., Desiato V.M., Yoo F., Nguyen, S.A., Schlosser, R.J. 2020, "Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors", International Forum of Allergy and Rhinology 10(2), 199-207

5

Ad.5 VI.2: Hasan, D., Blankman, P., Nieman, G.F. 2017, "Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury", Purinergic Signalling 13(3), 363-386

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

APVV-17-0250: "Pulmonary surfactant as a modulator of body´s response to endotoxin exposure: effects and mechanisms". 2018 - 2022, responsivle investigator

2

APVV-15-0075: "Perspectives of the use of ventilator AURA V (Chirana, SR) in the treatment of experimental models of respiratory failure in the neonates". 2016 - 2020, responsible investigator

3

VEGA 1/0004/21: "Synthetic surfactant with surfactant analogues SP-B and SP-C and anti-inflammatory therapy in experimental acute respiratory distress syndrome (ARDS)". 2021 - 2024, responsible investigator

4

VEGA 1/0055/19: "Pulmonary surfactant as a part of protective mechanisms of the respiratory system: utilization of three models". 2019 - 2022, deputy Investigator

5

VEGA 1/0356/18: "Effect of experimentally induced lung damage on extrapulmonary organs". 2018 - 2021, responsible investigator

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2025-02-27